HOME >> MEDICINE >> NEWS
A threatened St. Johns wort plant could be more effective as an anti-depressant, Cornell and USDA researchers find

ver, not all St. John's wort products are the same. Previous studies have shown that the amount of hypericin in the plant - although usually labeled can vary from plant to plant, manufacturer to manufacturer, bottle to bottle and pill to pill. Thus Sirvent and Gibson are trying to determine how much of a role pre-harvest factors play in chemical differences. They are examining factors such as light, moisture, altitude and latitude; the plant parts; the plant's development stage; and the harvesting and handling practices that might affect the quality of the final product. Additionally, variations in St. John's wort products sometimes occur because manufacturers mix species of H. perforatum.

The plant typically is gathered as a weedy species in the western United States, but some is being grown commercially in the Pacific Northwest. It also is found along roadways and in fields in the eastern United States. Hypericin is concentrated in little black nodules nearly imperceptible to the untrained eye that adorn the floral edges and the plant's leaves. Curiously, St. John's wort is considered a noxious weed that can cause hypericism, or blistering and dyeing of an animal's skin when it is eaten. Its scraggly, almost frail-looking stem produces a brilliant yellow flower cluster and it grows readily in rock quarries and in marginal areas such as roadsides, where little else grows.


'"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-255-3290
Cornell University News Service
14-Aug-2000


Page: 1 2

Related medicine news :

1. Caregivers refuse Alzheimers medications when patients quality of life threatened
2. Johns Hopkins scientists receive presidential medals
3. Robert Wood Johnson Medical School researcher receives fellowship for work in Canavan Disease
4. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
5. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
6. Johns Hopkins To Announce AIDS Capitated Care Program
7. Success of liver transplantation may be most influenced by three risk factors
8. Tracking trends in cochlear implant complications using a federal database
9. Alcohol relapse adversely affects 10-year liver transplant survival
10. Donor age has no affect on long-term liver transplant survival
11. Age shouldnt be a factor in kidney transplantation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... , ... The Margarian Law Firm has filed a class action lawsuit ... allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ale ... Canada Dry Ginger Ale claims on its bottle that it is made from real ...
(Date:7/21/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... to solve problems and pleads with world leaders to be more open about positive changes. ... peace. He says there is a peaceful and positive way to solve all; yes, all ...
(Date:7/21/2017)... (PRWEB) , ... July 21, 2017 , ... ... has received a $5,000 grant from the C. R. Bard Foundation, Inc. ... Center at Somerset Hills , a service available through the nonprofit home care ...
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. Louis-based ... the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , The ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... Did you know that PhRMA member companies invested $65.5 ... spending on brand medicines, generics and the supply chain account for ... just half of this (7 percent)? Or that the ... venture capital investments in high-growth biopharmaceutical startups? ... The biopharmaceutical ...
(Date:7/20/2017)... 2017  Prime Therapeutics LLC (Prime) released this statement from ... today,s Institute for Clinical and Economic Review,s (ICER) public ... and value of abuse-deterrent formulations (ADF) of opioids. Prime was ... the meeting. "The ... to the use of abuse-deterrent formulations (ADF) in opioids in ...
(Date:7/19/2017)...  Mako Medical Laboratories partnered with Secretary Strickland, the ... Fund (MFA) to bring 140 soldiers back home to ... families one last time before being deployed. Mako Medical ... logistics needed for these soldiers. "Mako Medical Laboratories is ... We just wish we could bring them all home," ...
Breaking Medicine Technology:
Cached News: